Sydney researchers have
identified how nanomedicine
technology can deliver “gene
silencing” drugs to pancreatic
cancer tumours that have proven
notoriously difficult to treat.
Scar tissue has been the biggest
hurdle because it can make up to
90% of the tumour, scientists said,
and this blocks therapeutic drugs
from reaching the tumour so it is
resistant to chemotherapy.
NSW University pancreatic cancer
translational research group head
Dr Phoebe Phillips said the new
drug delivery form can penetrate
the scar tissue barrier, making the
tumour susceptible to therapies.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Aug 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Aug 16
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.